Prot #GFT505-212-7: A Study to Evaluation the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients with Non-Alcoholic Steatohepatitis (NASH), A Multicenter, Randomized, Double Blind, Placebo-Controlled Study, with an Adaptive Design to